Journal: bioRxiv
Article Title: Calpain-2 regulates hypoxia/HIF-induced amoeboid reprogramming and metastasis
doi: 10.1101/2020.01.06.892497
Figure Lengend Snippet: a, In-silico modelling of cell elongation. Individual cell migration in dependence of friction and contractility using a two-dimensional phase field simulation. b, Active and total β1 integrin protein content (2D monolayer culture). D, densitometric analysis (representative Western blot, n=2-3). c, Schematic of cell isolation for harvesting attached (highly adhesive) and detached (weakly adhesive) cells in 2D culture. d, Active and total β1 integrin surface expression (MFI) in 4T1 subpopulations 48 h after treatment (left panel, representative flow cytometry histogram). Ratio of active/total β1 integrin surface expression normalized to vehicle control ratios (right panel). Columns show the median from independent experiments (data points). ** P=0.007, * P=0.03 (unpaired t-test, two-sided). e, Confocal micrographs of active (mAb 9EG7) and total β1 integrin (mAb CD29) expression of 4T1 tumoroids invading into 3D collagen (left panel) and the ratio of active/total β1 integrin per invading 4T1 single cell (right panel, 106 cells). Data show ratios of single cells; horizontal lines the median. Insets, single cell invasion phenotypes (arrowheads). Scale bars, 100 μm (overview), 10 µm (inset). **** P<0.0001 (Mann-Whitney test, two-sided). f, Brightfield micrographs of tumoroids after 72 h of 3D collagen invasion (left panel) and morphology-based single-cell subtypes (right panel) for indicated conditions in the presence or absence of β1 integrin-activating mAb 9EG7. Insets, morphologies of migrating single-cells. Data show the experimental means ± s.d. (5 tumoroids/condition each experiment, n=3). **** P<0.0001, *** P=0.0008, ** P<0.006, * P<0.03 (two-way ANOVA). Abbreviations: E, elongated; P pseudopodal-amoeboid; B, blebbing-amoeboid; N, normoxia; H, hypoxia; V, vehicle (DMSO); D, DMOG.
Article Snippet: The following antibodies and dyes were used: rabbit polyclonal anti-HIF1α (1:1000 WB, Novus Biologicals, 100-479), rabbit polyclonal anti–calpain-2 large subunit (1:1000 WB, Cell Signaling, 2539), chicken polyclonal anti-β-actin (1:1000 WB, Abcam, 13822), rabbit polyclonal anti-β-actin (1:2000 non-reducing WB in 4T1, Cell Signaling, 4967), rabbit polyclonal anti–talin-1 (clone 8d4; 1:200 WB, Sigma-Aldrich, T3287), mouse monoclonal anti-human CD29 (activated β1-integrin, clone HUTS-4; 1:500 WB, MerckMillipore, 2079Z), mouse monoclonal anti-human CD29 (clone 4B4; 1:1000 WB, 0.5-10 μg/ml functional studies, Beckman Coulter, 6603113), rat monoclonal anti-mouse CD29 (primed β1-integrin, clone 9EG7; 1:500 WB, 1:25 FC, 1:50 IF, BD Biosciences, 553715), rabbit monoclonal anti-mouse CD29 (clone EP1041Y; 1:1000 WB, Millipore, 04-1109), rat IgG2a isotype control (Clone R5-95; 1:25 FC, BD Biosciences, 553927), FITC-conjugated Armenian hamster anti-CD29 (clone HMβ1-1; 1:100 IF, 1:50 FC, Biolegend, 102206), FITC-conjugated Armenian hamster IgG (CloneHTK888; 1:20 FC, Biolegend, 400906), rabbit anti-cleaved caspase-3 (1:200 IF, Cell Signaling, 9664), mouse anti-human CD29 (clone TS2/16; 20 μg/ml, BioLegend, 303010), rabbit-on-rodent HRP-polymer (IHC, Biocare Medical, RMR622), rabbit monoclonal anti-cytokeratin 8 (clone EP1628Y; 1:250 IHC, Abcam, 53280), secondary goat anti-rabbit/mouse/chicken antibodies conjugated to horseradish peroxidase (1:10,000 WB, Jackson, 211-032-171/115-0450174/ 103-035-155), secondary goat anti-rat IgG AF488 (1:200 FC, Thermo Fisher Scientific, 11006), secondary goat anti-rat IgG AF647 (1:200 IF, Thermo Fisher Scientific, A21247), secondary goat anti-rabbit IgG AF633 (1:200 IF, Thermo Fisher Scientific, A21071), phalloidin AF488/546/568/633 (1:100 IF, Thermo Fisher Scientific, A12379/A22283/A12380/A22284), DAPI (1:500 IF, Thermo Fisher Scientific, D21490).
Techniques: In Silico, Migration, Western Blot, Cell Isolation, Adhesive, Expressing, Flow Cytometry, Control, MANN-WHITNEY